Sotera Health (SHC) Competitors

Sotera Health (NASDAQ:SHC) and Fresenius Medical Care (NYSE:FMS) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, community ranking, media sentiment, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends.

Is SHC or FMS more profitable?

Sotera Health has a net margin of 6.31% compared to Fresenius Medical Care's net margin of 3.43%. Sotera Health's return on equity of 42.27% beat Fresenius Medical Care's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sotera Health	6.31%	42.27%	6.02%
Fresenius Medical Care	3.43%	6.04%	2.69%

Does the MarketBeat Community believe in SHC or FMS?

Fresenius Medical Care received 373 more outperform votes than Sotera Health when rated by MarketBeat users. However, 58.14% of users gave Sotera Health an outperform vote while only 54.72% of users gave Fresenius Medical Care an outperform vote.

Company	Underperform	Outperform
Sotera Health	Outperform Votes 50 58.14%	Underperform Votes 36 41.86%
Fresenius Medical Care	Outperform Votes 423 54.72%	Underperform Votes 350 45.28%

Do institutionals & insiders hold more shares of SHC or FMS?

91.0% of Sotera Health shares are held by institutional investors. Comparatively, 8.4% of Fresenius Medical Care shares are held by institutional investors. 55.1% of Sotera Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Which has more volatility and risk, SHC or FMS?

Sotera Health has a beta of 1.91, suggesting that its share price is 91% more volatile than the S&P 500. Comparatively, Fresenius Medical Care has a beta of 0.93, suggesting that its share price is 7% less volatile than the S&P 500.

Do analysts recommend SHC or FMS?

Sotera Health presently has a consensus price target of $16.08, indicating a potential upside of 18.96%. Fresenius Medical Care has a consensus price target of $25.30, indicating a potential upside of 9.59%. Given Sotera Health's stronger consensus rating and higher probable upside, research analysts plainly believe Sotera Health is more favorable than Fresenius Medical Care.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67
Fresenius Medical Care	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

Which has higher valuation & earnings, SHC or FMS?

Fresenius Medical Care has higher revenue and earnings than Sotera Health. Fresenius Medical Care is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.12B	3.42	$51.38M	$0.25	54.08
Fresenius Medical Care	$21.05B	0.64	$540.07M	$1.21	19.08

Does the media favor SHC or FMS?

In the previous week, Sotera Health had 6 more articles in the media than Fresenius Medical Care. MarketBeat recorded 9 mentions for Sotera Health and 3 mentions for Fresenius Medical Care. Fresenius Medical Care's average media sentiment score of 1.56 beat Sotera Health's score of -0.17 indicating that Fresenius Medical Care is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sotera Health	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral
Fresenius Medical Care	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Sotera Health beats Fresenius Medical Care on 13 of the 18 factors compared between the two stocks.